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The study of the effect of bis 3-azophenyl-4-hydroxy-6-methyl-pyran-2-one cobalt (II) as 
chemotherapeutic agent was undertaken with the intention of studying the effects in 7,12-
dimethylbenz[a] anthracene (DMBA) and tetradecanoyl phorbol-13-acetate (TPA) induced chemical 
carcinogenesis on skin of 5 - 7 weeks old healthy albino rats. The animals were divided into 5 groups 
(A, B, C, D and E) of twenty each. The rats were treated with carcinogens for 15 weeks and then the 
curative effect of bis 3-azophenyl-4-hydroxy-6-methyl-pyran-2-one cobalt (II) was observe. The bis 3-
azophenyl-4-hydroxy-6-methyl-pyran-2-one cobalt (II) prevents malignant conversion of chemically 
induced benign tumors and did not kill cancer cells but change them to normal cells. It was concluded 
that if the complex is given in the pre-malignant phase of tumor development, it decreases the risk of 
malignant transformation. 
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Cell division or cell proliferation is a physiological process 
that occurs in almost all tissues under different circum-
stances. Normally, the balance between proliferation and 
programmed cell death is tightly regulated to ensure the 
integrity of organs and tissues. Mutations in DNA that 
lead to cancer disrupt these orderly processes. Leong 
and Leong (1989) realized that tumor in body behaved in 
different ways. The uncontrolled and often rapid 
proliferation of cells can lead to either a benign tumor or a 
malignant tumor (cancer). Benign tumors do not spread 
to other parts of the body or invade other tissues, and 
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TPA, 12-O-tetradecanoy-1-phorbol-13-acetate; DMF, dimethyl-
formamide. 
compress vital structures. Malignant tumors can invade 
other organs, spread to distant locations (metastasize) 
and become life threatening.  
Tumorigeneses by carcinogens usually occur in multi 
step, the first two steps are known as initiation and 
promotion, while the third step is progression during 
which the transformed cell develops into malignant cells. 
The most widely used drugs in chemotherapy (Rosenberg 
and Camp, 1970) are metal-based drugs. There are 
many other transition metals that exhibit role of powerful 
anti-cancer agent. 
Pyrones and their derivatives have been widely ackno-
wledged compounds, an account of the fact that they are 
natural products. Pyrones has displayed remarkable 
utility for antibacterial and antifungal (Rehman et al., 
2005). The transitional metal complexes with hetrocyclic 
systems containing nitrogen and sulphur atoms have 
been studied extensively because of antitumor (Rosonberg 
and Camp, 1970; Bhatti et al., 2001; Chohan et al., 2003, 
Dollet and Sorenson, 1985) activities. The study was 
undertaken with the intention  of  studying  the  effects  of 
 









Carcinogen (For 15 weeks) Complex (For 15 weeks) 
DMBA in acetone (100 
µg/ml) 
TPA in acetone (10 µg/ml) after 2 
weeks of DMBA till 15 weeks 
Complex in DMF (10 µg/ml) after 15 
weeks of carcinogenesis till 30 
weeks 
Route Schedule Route Schedule Route Schedule 
A Nil Nil NIL Nil Nil Nil 
B and C Nil Nil NIL Nil Nil Nil 
D Topical  Single dose Topical Twice a week till 15 weeks Nil Nil 
E Topical  Single dose Topical Twice a week till 15 weeks Topical Twice a week till 30 weeks 
 




chemical carcinogens on the skin of rats with initiation-
promotion protocol and the use of previously reported 
complex bis-3-azophenyl-4-hydroxy-6-methyl-pyran-2-




MATERIALS AND METHODS 
 
7,12-Dimethy1 benz(a) anthracence (DMBA), used as initiator and 
12-O-tetradecanoy-1-phorbol-13-acetate (TPA) were purchased 
from Sigma Chemical Company and the study was done at the 
Postgraduate Medical Institute Lahore, Pakistan. Hundred albino 
rats were used for the study. They were divided into five groups 
(twenty each) of A, B, C, D and E. The animals used in the 
experiment were healthy and adult were kept under optimal 
atmospheric and hygienic conditions. All the five groups were kept 
in separate iron cages fitted with removable gauze lids and were 
labeled with their respective identification markings. 
The animals were allowed and facilitated to acclimatize in the 
house for one week before the experiment was started. After one 
week of acclimatization of the rats, the back of each rat was shaved 
off hair (5 x 5 cm area) with electric clipper, this was done three 
days before the first dose was administrated. Two chemicals were 
used as carcinogens, DMBA was used as initiator and TPA was 
used as promoter in the experimental study. Freshly prepared 
solution of DMBA in acetone (100 µg/ml) as a single dose was 
applied on the skin of the albino rats (Mughal, 2005). Insulin 
syringes were used for the application of solution. After two weeks 
of application of DMBA, TPA (10 µg/ ml in acetone) was applied 
twice, a week after (Slaga et al., 1990; Bukhari et al., 2002).  
 
 
Group A  
 
The animals of group A acted as control and were not given any 
treatment throughout the experimental period (30 weeks). 
 
 
Groups B and C  
 
The animals of groups B and C also acted as control. However, 
these animals received doses of acetone and dimethylformamide 
(DMF), the vehicles used for dilution of carcinogens and bis 3-
azophenyl-4-hydroxy-6-methyl-pyran-2-one cobalt (II) (Table 1). 
Group D 
 
The animals of this group were administered with DMBA at 100 
µg/ml topically, as single dose on the shaved dorsum of the albino 
rats’ skin, after two weeks. TPA was applied twice a week till 15 






Animals of group E were given carcinogens (DMBA and TPA) in the 
same schedule as for other animals (Table 1). In this group, 
complex was given locally after 15 weeks of carcinogenesis in a 
dose of 10 µg/ml twice a week for the next 15 weeks to observe the 
response of locally applied given complex against chemical 
carcinogens (Table 1). After completion of 30 weeks, biopsies were 
taken to see the chemotherapeutic response of locally applied 
given complex against chemical carcinogens. 
 
 
Particulars of lesion recorded 
 
Every week, loss of hair and gross morphological features such as 
ulcers were closely observed in each animal and if found, where 
measured carefully with Vernier calipers throughout the experiment. 
After the completion of fifteen weeks, the lesions and the 
surrounding skin of each animal was also closely examined (by a 
true cut fine needle biopsy) with a microscope to determine the 
extent of histopathological changes, such as papiloma, squamous 
cell carcinoma, malignant fibrous histiocytoma, atrophy, fibro-
sarcoma, chronic inflammation, squamous cell carcinoma in situ 
and osteoma at the end of the experiment. The lesions were then 
diagnosed according to the histopathological changes by using 
ether to anesthetize the rats. All the animals were sacrificed and 
after removing sections of the rats’ dorsal skin, sections that 
contained or surrounded the lesion were removed for further 
cutting. The cancerous and surrounding tissues were washed two 






Histopathological examination was done according to Hopwood et 
al. (1990), Gorden et al. (1990) and Steven, (1990), the following 
steps   were  taken:  Fixation   stages   in   tissue  processing, gross 
 






Figure 1. Photomicrograph showing a papilloma on the skin of 










examination, sectioning of the tissues, processing for the section, 
clearing: wax impregnation, embedding, storage of blocks, trimming 
of blocks, section cutting, removal of paraffin wax, hydration, 
staining, oiling and clearing and mounting. 
 
 
RESULTS AND DISCUSSION 
 
The maximum number of lesions were found in group D 
(100%), while no tumor was observed in the control 
groups (A, B and C) (Figure 3). All animals received 
topical application of DMBA and TPA. In group D, 14 
animals developed benign lesions which were epidermal 
hyperplasia (07), osteoma (01), dysplasia (03), papiloma 
(03) (Figure 1). There were (06) malignant lesions which 
were squamous cell carcinoma in situ (02), squamous 
cell carcinoma (02) and malignant fibrous histiocytoma 
(02) (Figures 1 and 2). Most of the rats had chronic 







Figure 3. Photomicrograph showing normal epidermal and 




Hair loss was observed on specific areas on the third 
week where DMBA and TPA were applied locally. Post 
application of DMBA and TPA showed slight bleeding 
and ulceration which was not too deep, and this was 
observed at 14 weeks. Small size out growths (pinkish 
white color) were also observed (papilloma) at 15 weeks 
in the treated area. 
In group E, 14 animals developed benign lesions which 
were epidermal hyperplasia (08), papilloma (03) and 
dysplasia (03). Five animals developed malignant lesions 
squamous cell carcinoma (02), squamaous cell 
carcinoma in situ (02) and malignant fibrous histiocytoma 
(01) (Table 1) after 15 weeks of carcinogenesis. When 
the chemotherapy was given to this group, all the benign 
lesion were cured and the hair of the rats grew back after 
some time, while malignant lesions remained the same 
as they were before chemotherapy (Table 2). Our 
findings are consistent with Limtrakul et al. (2003) and 
Richardson et al. (2006) who used iron complex as an 
antitumor. 
The role of metallic compounds as anti-tumor agent 
has well been established. Cis-platinum complexes are 
particularly effective in combination with other drugs in 
the treatment of other tumors of testes, ovary, head and 
neck and lung. Platinum complexes with amino ligands 
and steroid derivative show anti-tumor activity in which 
the metal is coordinated by dehydrocholic acid and a 
phosphine. Similarly, bleomycin is a clinically used anti-
tumor agent. It is isolated from Streptomyces verticillus 
as a copper complex and is a compound used in many 
tumors, e.g. lymphoma and testicular cancers. The use of 
iron chelators as clinical agents against cancer is an area 
of growing interest. Previously, the di-2-pyridylketone 
isonicotinoyl hydrazone analogues were identified as 
ligands with potent and selective antineoplastic activity 
that can induce the expression of molecules involved in 
cell   cycle   arrest.  This  study  also  showed  that  these  
 




Table 2. Distribution of lesions obtained in different animals with carcinogens and bis 3-azophenyl-4-hydroxy-6-methyl-pyran-2-
one cobalt (II). 
 
Group 
Benign lesion Malignant lesion Total lesion 
(%) EPA Pap Dys OST Total SQCCIS SQCC MFH Total 
A (control) - - - - - - - - - 0% 
B - - - - - - - - - 0% 
C - - - - - - - - - 0% 
D 7 3 3 1 14 2 2 2 6 20 (100%) 
E (before complex) 8 3 3 - 14 2 2 1 5 19 (95%) 
E (after complex) - - - - - 2 2 1 5 5 (25%) 
 
EPH, Epidermal hyperplasia; Pap, papilloma; Dys, dysplasia; SQCCIS, squamous cell carcinoma in situ; SQCC, squamous cell 




chelators have high chelation efficacy, indicating a 
potential mechanism of anti-tumor activity. The di-2-
pyridylketone isonicotinoyl hydrazone chelators with 
greatest anti-proliferative activity effectively entered cells, 
bound iron, induced iron mobilization and prevented iron 
uptake from transferring. The results suggested that the 
antiproliferative effects of these chelators relates to 
intracellular iron chelation, followed by the stimulation of 
iron mediated free radical generation via the so formed 
iron complex.  
Our study was designed to see the effect of bis 3-
azophenyl-4-hydroxy-6- methyl-pyran-2-one cobalt (II) 
(complex) in DMBA, followed by TPA, induced chemical 
carcinogens on the skin of albino rats. No tumor deve-
loped in the first and second group. However, rats 
belonging to the third group to whom no chemotherapy 
was given developed malignant tumors which became 
worse and two animals bearing these malignant tumors 
died before the completion of the experimental period. 
Our study suggested that use of iron complex decreases 
the risk of malignant conversion of benign tumors, 
because all benign tumors and premalignant lesions were 
cured with the use of bis 3-azophenyl-4-hydroxy-6-
methyl-2h-pyran-2-one cobalt (II). Our findings are 
consistent with Richardson et al. (2006). They also used 
the iron complex (diphenyl thiosemicarbazone) as an 
anti-tumor agent. 
This study is encouraging as it suggests that if the 
complex is given in the pre-malignant phases of tumor 
development, it decreases the risk of malignant transfor-
mation. There is immense scope for further research on 
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